This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Institut De Radioprotection Et De Surete Nucleaire. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Marc Benderitter
Introduction
Marc Benderitter is a notable inventor based in L'Hay les Roses, France. He has made significant contributions to the field of tissue regeneration, particularly in the context of post-irradiation recovery. His work focuses on utilizing adipose-tissue cell fractions to promote healing and regeneration.
Latest Patents
Marc Benderitter holds a patent for the "Use of adipose-tissue cell fractions for post-irradiation tissue regeneration." This invention concerns the application of cells derived from the cellular fraction of the vascular stroma of extramedullary adipose tissue. The aim is to promote tissue regeneration following lesions caused by irradiation. Specifically, this invention seeks to prepare a drug that facilitates the regeneration of skin and aids in repairing cutaneous wounds resulting from irradiation. He has 1 patent to his name.
Career Highlights
Marc Benderitter is associated with the Institut de Radioprotection et de Sûreté Nucléaire, where he applies his expertise in radiation protection and safety. His work at this institution underscores his commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout his career, Marc has collaborated with esteemed colleagues such as Radia Tamarat and Odile Carvalho. These partnerships have likely enriched his research and contributed to the success of his innovative projects.
Conclusion
Marc Benderitter's contributions to the field of tissue regeneration highlight the importance of innovation in medical science. His patent on adipose-tissue cell fractions represents a significant advancement in the treatment of radiation-induced injuries. His work continues to inspire future research and development in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile